Skip to content

Clinical trials

Hypersensitivity trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Country / region: Netherlands Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20063
20071
20083
20101
20121
20142
20152
20161
20172
20181
20212
20222
20233
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting4
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aimmune Therapeutics, Inc.3
Artu Biologicals3
Cogent Biosciences, Inc.2
Maastricht University Medical Center2
Novartis Pharmaceuticals2
ALK-Abelló A/S1
Agentschap NL1
AstraZeneca1
DBV Technologies1
Erasmus Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity27
Immune System Diseases4
Peanut Hypersensitivity4
Asthma3
Eczema2
Hematologic Diseases2
Hypersensitivity, Immediate2
Immune Complex Diseases2
Mastocytosis2
Mastocytosis, Systemic2

Trials

Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.